AIDS (London, England)
Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens.
Anne-Geneviève Marcelin, Cathia Soulie, Marc Wirden, Joshua Gruber, Neia Prata Menezes, Travis Lim, Guillaume Barriere, Diane Descamps, Charlotte Charpentier, Vincent Calvez
Published: 202510.1097/QAD.0000000000004438
Abstract
OBJECTIVE: To assess the prevalence and patterns of treatment-emergent resistance-associated mutations (RAMs) in people with HIV (PWH) with ≥1 prior regimen experiencing virologic failure (VF) with bictegravir/emtricitabine/tenofovir alafenamide (B/F…
Preview only. Read the full abstract at the source